Results 251 to 260 of about 93,286 (337)

Establishment and Validation of a C57BL/6J Mouse Model for Melasma

Cell Proliferation, EarlyView.
A melasma‐like mouse model was established in C57BL/6J mice using a combination of UVB irradiation, progesterone administration, and chronic psychological stress. This model replicates key clinical features and biomarker alterations observed in human melasma. Importantly, it is fundamentally distinct from UV‐induced post‐inflammatory hyperpigmentation (
Wenzhu Wang, Xiaojie Sun, Yunyao Liu, Yin Yang, Hedan Yang, Xiaoli Zhang, Xiuzhen Li, Haoxiang Xu, Xu Chen, Tong Lin   +9 more
wiley   +1 more source

The Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in Gynecological Cancers: A Narrative Review. [PDF]

Cureus
Flindris S, Flindris K, Foutadakis S, Kalinderis M, Traianos A, Kigka VI, Nteka F, Mpourazanis G, Styliara I, Styliara E, Tsirkas P, Petousis S, Margioula-Siarkou C, Navrozoglou I.   +13 more
europepmc   +1 more source

Tumour Cell Size Control and Its Impact on Tumour Cell Function

Cell Proliferation, EarlyView.
The regulatory mechanism of the size of tumour cells and its impact on the functions of tumour cells, as well as a summary of potential therapeutic targets for the corresponding mechanisms. ABSTRACT Cell size is an important component of cell morphological characteristics.
Min Zhou, Mei Zhou, Yang Jin
wiley   +1 more source

REST corepressor 2 contributes to the cell proliferation of endometrial cancer. [PDF]

Front Oncol
Zhu Q, Yang X, Lv Y.
europepmc   +1 more source

The Efficacy of Pembrolizumab Immunotherapy in the Treatment of Endometrial Cancer: A Systematic Review. [PDF]

Int J Mol Sci
Picheta N, Piekarz J, Kułak K, Tarkowski R.   +3 more
europepmc   +1 more source

Mapping the relationship between obesity and endometrial cancer: current research hotspots and future trends (2003-2024). [PDF]

Front Oncol
Liang L, Song C, Yang B, Chang C, Chen S, Sun L.   +5 more
europepmc   +1 more source

A case report of recurrent endometrial cancer invading the rectum and bladder with concurrent primary rectal cancer treated with total neoadjuvant therapy and pelvic exenteration. [PDF]

J Surg Case Rep
Mazraani B, Simpson Q, Bolliet M, Hao S, Wasvary H.   +4 more
europepmc   +1 more source

Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer. [PDF]

Cancers (Basel)
Li H, Zhang R, Sui T, Wang K, Li Y, Luo X, He Q.   +6 more
europepmc   +1 more source

[Endometrial neoplasms. What to consider?].

Revista da Associacao Medica Brasileira (1992), 2005
openaire   +1 more source